PharmacoEconomics & Outcomes News

, Volume 807, Issue 1, pp 11–11 | Cite as

Cost-effectiveness models for disease-modifying therapies in MS

Clinical study


  1. Hernandez L, et al. Modeling Approaches in Cost-Effectiveness Analysis of Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: An Updated Systematic Review and Recommendations for Future Economic Evaluations. PharmacoEconomics : 3 Jul 2018. Available from: URL:

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations